B-cell subsets and the mature preimmune repertoire. Marginal zone and B1 B cells as part of a ″natural immune memory″

Immunological Reviews

Volumn 175, Issue , 2000, Pages 70-79

  Martin, Flavius ^a   Kearney, John F ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; BACTERIAL ANTIGEN; CD19 ANTIGEN; CD23 ANTIGEN; CD40 ANTIGEN; COMPLEMENT COMPONENT C3D RECEPTOR;

ANIMAL CELL; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIGEN SPECIFICITY; ARTICLE; B LYMPHOCYTE; BACTERIAL INFECTION; CELL ACTIVITY; CELL CLONE; CELL HETEROGENEITY; CELL MATURATION; CONTROLLED STUDY; DUCK; EFFECTOR CELL; IMMUNE RESPONSE; IMMUNOLOGICAL MEMORY; LYMPHOCYTE SUBPOPULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN;

ANIMALS; ANTIGENS, BACTERIAL; ANTIGENS, T-INDEPENDENT; B-LYMPHOCYTE SUBSETS; CELL DIFFERENTIATION; CELL LINEAGE; IMMUNOGLOBULIN HEAVY CHAINS; IMMUNOGLOBULIN LIGHT CHAINS; IMMUNOLOGIC MEMORY; LYMPHOID TISSUE; MICE; MICE, TRANSGENIC; MODELS, BIOLOGICAL; RECEPTORS, ANTIGEN, B-CELL; SPLEEN;

EID: 0033919320     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-065X.2000.017515.x     Document Type: Article

References (90)

1. 1. Melamed D, Benschop RJ, Cambier JC, Nemazee D. Developmental regulation of B lymphocyte immune tolerance compartmentalizes clonal selection from receptor selection. Cell 1998;92:173-182.
2. 2. Loder F, et al. B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. J Exp Med 1999;190:75-89.
3. 3. Hartley SB, et al. Elimination of self-reactive B lymphocytes proceeds in two stages: arrested development and cell death. Cell 1993;72:325-335.
4. 4. Carsetti R, Kohler G, Lamers MC. Transitional B cells are the target of negative selection in the B cell compartment. J Exp Med 1995;181:2129-2940.
5. 5. Cyster JG. Signaling thresholds and interclonal competition in preimmune B cell selection. Immunol Rev 1997;156:87-101.
6. 6. MacLennan IC, Gray D. Antigen-driven selection of virgin and memory B cells. Immunol Rev 1986;91:61-85.
7. 7. Hayakawa K, Li YS, Wasserman R, Sauder S, Shinton S, Hardy RR. B lymphocyte developmental lineages. Ann N Y Acad Sci 1997;815:15-29.
8. 8. Spanopoulou E, et al. Functional immunoglobulin transgenes guide ordered B cell differentiation in Rag-1 deficient mice. Genes Dev 1994;8:1030-1042.
9. 9. Young F, et al. Influence of immunoglobulin heavy-and light-chain expression on B-cell differentiation [published erratum appears in Genes Dev 1995;9:3190]. Genes Dev 1994;8:1043-1057.
10. 10. Taki S, Meiering M, Rajewsky K. Targeted insertion of a variable region gene into the immunoglobulin heavy chain locus. Science 1993;262:1268-1271.
11. 11. Sonoda E, et al. B cell development under the condition of allelic inclusion. Immunity 1997;6:225-233.
12. 12. Cascalho M. Ma A, Lee S, Masat L, Wahl M. A quasi-monoclonal mouse. Science 1996;272:1649-1652.
13. 13. Cascalho M, Wong J, Wahl M. VH gene replacement in hyperselected B cells of the quasimonoclonal mouse. J Immunol 1997;159:5795-5801.
14. 14. Martin F, Chen X, Kearney JF. Development of VH81X transgene-hearing B cells in fetus and adult: sites for expansion and deletion in conventional and CD5/B1 cells. Int Immunol 1997;9:493-505.
15. 15. Cyster JG, Hartley SB, Goodnow CC. Competition for follicular niches excludes self reactive cells from the recirculating B-cell repertoire. Nature 1994;371:389-395.
16. 16. Kenny JJ, Finkelman F. Macchiarini F, Kopp WC, Storb U, Longo DL. Alteration of the B cell surface phenotype, immune response to phosphocholine and the Bcell repertoire in M167 μ + κ transgenic mice. J Immunol 1989;142:4466-4474.
17. 17. Arnold LW, Pennell CA, McCray SK, Clarke SH. Development of B-1 cells: segregation of phosphatidyl choline-specific B cells to the B-1 population occurs after immunoglobulin gene expression. J Exp Med 1994;179:1585-1595.
18. + B cells. Immunol Rev 1994;137:91-118.
19. 19. Lam KP, Rajewsky K. B cell antigen receptor specificity and surface density together determine B-1 versus B-2 cell development. J Exp Med 1999;190:471-477.
20. 20. Watanahe N. Nisitani S, Ikuta K, Suzuki M, Chiba T, Honjo T. Expression levels of B cell surface immunoglobulin regulate efficiency of allelic exclusion and size of autoreactive B-1 cell compartment. J Exp Med 1999;190:461-469.
21. 21. Chen X. Martin F, Forbush KA, Perlmutter RM, Kearney JF. Evidence for selection of a population of multi-reactive B cells into the splenic marginal zone. Int Immunol 1997;9:27-41.
22. 22. Martin F, Kearney JF. Positive selection from newly formed to marginal zone B cells depends on the rate of clonal production, CD19, and btk. Immunity 2000;12:39-49.
23. high lymphocytes enriched in the splenic marginal zone generate effector cells more rapidly than the bulk of follicular B cells. J Immunol 1999;162:7198-7207.
24. 24. Cong YZ, Rabin E, Wortis HH. Treatment of murine CD5 B cells with anti-Ig, but not LPS, induces surface CD5: two Bcell activation pathways. Int Immunol 1991;3:467-476.
25. 25. Inaoki M, Sato S, Weimraub BC, Goodnow CC, Tedder TF. CD19-regulated signaling thresholds control peripheral tolerance and autoantibody production in B lymphocytes. J Exp Med 1997;186:1923-1931.
26. 26. Cyster JG, Goodnow CC. Protein tyrosine phosphatase IC negatively regulates antigen receptor signaling in B lymphocytes and determines thresholds for negative selection. Immunity 1995;2:13-24.
27. 27. Murakami M, Nakajima K, Yamazaki K, Muraguchi T, Serikawa T, Honjo T. Effects of breeding environments on generation and activation of autoreactive B-1 cells in anti-red blood cell antoantibody transgenic mice. J Exp Med 1997;185:791-794.
28. + B cell precursor in B-1 cell differentiation. J Exp Med 1998;187:1325-1334.
29. 29. Kumararatne DS, MacLennan IC. The origin of marginal-zone cells. Adv Exp Med Biol 1982;149:83-90.
30. 30. Gray D, Kumararatne DS, Lortan J, Khan M, MacLennan IC. Relation of intra splenic migration of marginal zone B cells to antigen localization on follicular dendritic cells. Immunology 1984;52:659-669.
31. 31. Oliver AM, Martin F, Gartland GL, Carter RH, Kearney JF. Marginal zone B cells exhibit unique activation, proliferative and immunoglobulin secretory responses. Eur J Immunol 1997;27:2366-2374.
32. 32. Kumararatne DS, Bazin H, MacLennan IC. Marginal zones: the major B cell compartment of rat spleens. Eur J Immunol 1981;11:858-864.
33. 33. Liu YJ, Zhang J, Lane PJ, Chan EY, MacLennan IC. Sites of specific Bcell activation in primary and secondary responses to T cell-dependent and T cell-independent antigens. Eur J Immunol 1991;21:2951-2962.
34. 34. Kraal G. Cells in the marginal zone of the spleen. Int Rev Cytol 1992;132:31-74.
35. 35. Schmidt KN, Cyster JG. Follicular exclusion and rapid elimination of hen egg lysozyme autoantigen-binding B cells are dependent on competitor B cells, but not on T cells. J Immunol 1999;162:284-291.
36. 36. Grewal IS, et al. Requirement for CD40 ligand in costimulation induction, T cell activation, and experimental allergic encephalomyelitis. Science 1996;273:1864-1867.
37. 37. Campbell KA, Ovendale PJ, Kennedy MK, Fanslow WC, Reed SG, Maliszewski CR. CD40 ligand is required for protective cell-mediated immunity to Lashmania major. Immunity 1996;4:283-289.
38. 38. Oxenius A, et al. CD40-CD40 ligand interactions are critical in T-B cooperation but not for other anti-viral CD4T cell functions. J Exp Med 1996;183:2209-2218.
39. 39. Wang JH, et al. Aiolos regulates B cell activation and maturation to effector state. Immunity 1998;9:543-553.
40. + B) cells. Int Immunol 1992;4:243-252.
41. 41. Khan WN, et al. Defective B cell development and function in Btk-deficient mice. Immunity 1995;3:283-299.
42. 42. Kerner JD, et al. Impaired expansion of mouse B cell progenitors lacking Btk. Immunity 1995;3:301-312.
43. 43. Torres RM, Flaswinkel H, Reth M, Rajewsky K. Aberrant B cell development and immune response in mice with a compromised BCR complex. Science 1996;272:1804-1808.
44. 44. Ahearn JM, et al. Disruption of the Cr2 locus results in a reduction in B-1 a cells and in an impaired B cell response to T-dependent antigen. Immunity 1996;4:251-262.
45. 45. Molina H, et al. Markedly impaired humoral immune response in mice deficient in complement receptors 1 and 2. Proc Natl Acad Sci USA 1996;93:3357-3361.
46. 46. Tarakhovsky A, et al. Defective antigen receptor-mediated proliferation of B and T cells in the absence of Vav. Nature 1995;374:467-470.
47. 47. Engel P, Zhou LJ. Ord DC, Sato S, Koller B, Tedder TF. Abnormal B lymphocyte development, activation, and differentiation in mice that lack or overexpress the CD19 signal transduction molecule. Immunity 1995;3:39-50.
48. 48. Rickert RC, Rajewsky K, Roes J. Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature 1995;376:352-355.
49. β-deficient mice. Science 1996;273:788-791.
50. 50. Fruman DA, et al. Impaired B cell development and proliferation in absence of phosphoinositide 3-kinase p85α, Science 1999;283:393-397.
51. 51. Suzuki H, et al. Xid-like immunodeficiency in mice with disruption of the p85α subunit of phosphoinositide 3-kinase. Science 1999;283:390-392.
52. 52. Forster I, Gu H, Rajewsky K. Germline antibody V regions as determinants of clonal persistence and malignant growth in the B cell compartment. EMBO J 1988;7:3693-3703.
53. + B cell lymphomas. J Immunol 1988;141:2788-2796.
54. 54. SeidI KJ, MacKenzie JD, Wang D, Kantor AB, Kabat EA, Herzenberg LA. Frequent occurrence of identical heavy and light chain Ig rearrangements. Int Immunol 1997;9:689-702.
55. 55. Pennell CA, Mercolino TJ, Grdina TA, Arnold LW, Haughton, Clarke SH. Biased immunoglobulin variable region gene expression by Ly-1 B cells due to clonal selection. Eur J Immunol 1989;19:1289-1295.
56. + B lymphocytes. Int Immunol 1990;2:515-520.
57. 57. Hayakawa K, et al. Positive selection of natural autoreactive B cells. Science 1999;285:113-116.
58. 58. Goodnow CC, et al. Altered immunoglobulin expression and functional silencing of self-reactive B lymphocytes in transgenic mice. Nature 1988;334:676-682.
59. 59. Cyster JG, Healy JI, Kishihara K, Mak TW, Thomas ML, Goodnow CC. Regulation of B-lymphocyte negative and positive selection by tyrosine phosphatase CD45. Nature 1996;381:325-328.
60. 60. Lam KP, Kuhn R, Rajewsky K. In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell 1997;90:1073-1083.
61. 61. Gu H, Tarlinton D, Muller W, Rajewsky K, Forster L Most peripheral B cells in mice are ligand selected. J Exp Med 1991,173:1357-1371.
62. 62. Nadel B, Drapier AM, Andrade L, Cazenave PA, Sanchez P. Preferential VH/Vλ pairings occur in the available B cell repertoire of adult BALB/c mice. Int Immunol 1992;4:501-507.
63. 63. Hachemi-Rachedi S, Cumano A, Drapier AM, Cazenave PA, Sanchez P Does positive selection determine the B cell repertoire? Eur J Immunol 1997;17: 1069-1074.
64. 64. Pandey A, Tjoelker LW, Thompson CB. Restricted immunoglobulin junctional diversity in neonatal Bcells results from developmental selection rather than homology-based V(D)J joining. J Exp Med 1993;177:329-337.
65. 65. Mason DY, Jones M, Goodnow CC. Development and follicular localization of tolerant B lymphocytes in lysozyme/anti-lysozyme IgM/IgD transgenic mice. Int Immunol 1992;4:163-175.
66. 66. Buiting AM, De RZ, Kraal G. Van RN. Humoral immune responses against particulate bacterial antigens are dependent on marginal metallophilic macrophages in the spleen. Scand J Immunol 1996;43:398-405.
67. 67. Seiler P, Aichele P, Odermatt B, Hengartner H, Zinkernagel RM, Schwendener RA. Crucial role of marginal zone macrophages and marginal zone metallophils in the clearance of lymphocytic choriomeningitis virus infection. Eur J Immunol 1997;27:2626-2633.
68. 68. Oldfield S, Lortan JE, Hyatt MA, MacLennan IC. Marginal zone B cells and the localisation of antigen on follicular dendritic cells. Adv Exp Med Biol 1988;237:99-104.
69. 69. Van der Laan LJ, et al. Macrophage scavenger receptor MARCO: in vitro and in vivo regulation and involvement in the anti-bacterial host defense. Immunol Lett 1997;57:203-208.
70. 70. Van der Laan LJ, et al. Regulation and functional involvement of macrophage scavenger receptor MARCO in clearance of bacteria in vivo. J Immunol 1999;162:939-947.
71. 71. Gijbels MJ, et al. Progression and regression of atherosclerosis in APOE3 Leiden transgenic mice: an immunohistochemical study. Atherosclerosis 1999;143:15-25.
72. 72. Ito S, et al. Roles of a macrophage receptor with collagenous structure (MARCO) in host defense and heterogeneity of splenic marginal zone macrophages. Arch Histol Cytol 1999;62:83-95.
73. 73. De Smedt T, et al. Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. J Exp Med 1996;184:1413-1424.
74. 74. Demoy M, Andreux JP, Weingarten C, Gouritin B, Guilloux V, Couvreur P. In vitro evaluation of nanoparticles spleen capture. Life Sci 1999;64:1329-1337.
75. 75. CysterJG, Goodnow CC Antigen induced exclusion from follicles and anergy are separate and complementary processes that influence peripheral B cell fate. Immunity 1995;3:691-701.
76. 76. Fulcher DA, et al. The fate of self-reactive B cells depends primarily on the degree of antigen receptor engagement and availability of T cell help. J Exp Med 1996;183:2313-2328.
77. 77. Cook MC, et al. Generation of splenic follicular structure and B cell movement in tumor necrosis factor deficient mice. J Exp Med 1998;188:1503-1510.
78. 78. Liu YJ. Sites of B lymphocyte selection, activation, and tolerance in spleen. J Exp Med 1997;186:625-629.
79. 79. Garcia DV, O'Leary P, Sze DM, Toellner KM, MacLennan IC. T independent type 2 antigens induce B cell proliferation in multiple splenic sites, but exponential growth is confined to extrafollicular foci. Eur J Immunol 1999;29:1314-1323.
80. 80. Garcia DV, et al. Dendritic cells associated with plasmablast survival. Eur J Immunol 1999;29:3712-3721.
81. 81. Roark JH, Park SH, Jayawardena J, Kavita U, Shannon M, Bendelac A. CD1.1 expression by mouse antigen presenting cells and marginal zone B cells. J Immunol 1998;160:3121-3127.
82. 82. Brossay L, et al. Mouse CD1 is mainly expressed on hemopoietic-derived cells. J Immunol 1997;159:1216-1224.
83. 83. Maher JK, Kronenberg M. The role of CD1 molecules in immune responses to infection. Curr Opin Immunol 1997;9:456-461.
84. 84. Ernst WA, et al. Molecular interaction of CD1b with lipoglycan antigens. Immunity 1998;8:331-340.
85. 85. Snapper CM, Rosas FR, Jin L, Wortham C, Kehry MR, Mond JJ. Bacterial lipoproteins may substitute for cytokines in the humoral immune response to T cell-independent type II antigens. J Immunol 1995;155:5582-5589.
86. 86. Snapper CM, Rosas FR, Kehry MR, Mond JJ, Wetzler LM. Neisserial porins may provide critical second signals to polysaccharide-activated murine B cells for induction of immunoglobulin secretion. Infect Immun 1997;65:3203-3208.
87. 87. Zinkernagel RM, Ehl S, Aichele P, Oehen S, Kundig T, Hengartner H. Antigen localisation regulates immune responses in a dose-and time-dependent fashion: a geographical view of immune reactivity. Immunol Rev 1997;156:199-209.
88. 88. Karras JG, Wang Z, Huo L, Howard RG, Frank DA, Rothstein TL. Signal transducer and activator of transcription 3 (STAT3) is constitutively activated in normal, self-renewing B-1 cells but only inducibly expressed in conventional B lymphocytes. J Exp Med 1997;185:1035-1042.
89. 89. Tanguay DA, et al. Early induction of cyclin D2 expression in phorbol ester-responsive B-1 lymphocytes. J Exp Med 1999;189:1685-1690.
90. - B cells differ in ability to stimulate antigen specific T cells. Arch Immunol Ther Exp (Warsz) 1994;42:115-123.